Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.
China is the largest supplier of Ibuprofen, with a production market share nearly 48% in 2016. India is the second largest supplier of Ibuprofen, enjoying production market share nearly 30.7% in 2016. Market competition is intense. Xinhua Pharmaceutical, IOLCP, Granules Biocause, Shasun, BASF and SI Group are the leaders of in the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Ibuprofen Market
The global Ibuprofen market is valued at US$ 294.4 million in 2019. The market size will reach US$ 437.6 million by the end of 2026, growing at a CAGR of 5.7% during 2021-2026.
Global Ibuprofen Scope and Market Size
Ibuprofen market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
USP
EP
Segment by Application
Tablet
Capsule
Suspension
Others
By Company
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Xinhua-Perrigo Pharmaceutical
Hisoar
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
China is the largest supplier of Ibuprofen, with a production market share nearly 48% in 2016. India is the second largest supplier of Ibuprofen, enjoying production market share nearly 30.7% in 2016. Market competition is intense. Xinhua Pharmaceutical, IOLCP, Granules Biocause, Shasun, BASF and SI Group are the leaders of in the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Ibuprofen Market
The global Ibuprofen market is valued at US$ 294.4 million in 2019. The market size will reach US$ 437.6 million by the end of 2026, growing at a CAGR of 5.7% during 2021-2026.
Global Ibuprofen Scope and Market Size
Ibuprofen market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
USP
EP
Segment by Application
Tablet
Capsule
Suspension
Others
By Company
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Xinhua-Perrigo Pharmaceutical
Hisoar
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
